FoodLabs Research
Investment Thesis
FoodLabs is a Berlin-based venture capital firm dedicated entirely to the intersection of food, agriculture, climate, and human health. The firm's public framing is unusually direct: "Backing the bold to Make cheese from microbes, not cows," a nod to their flagship portfolio bet on precision-fermentation dairy. FoodLabs believes the global food system is due for a structural overhaul, and that the founders capable of delivering it need patient, hands-on, sector-specialist capital rather than generalist money. The firm organizes its portfolio across five internal categories: Consumer, Supply Chains, Synbio (synthetic biology), Climate & Resilience, and Farming/Health.
Stage Focus
FoodLabs invests primarily at Pre-Seed, Seed, and selectively Series A. Its third fund, closed at EUR 105 million, is explicitly structured to write first checks into 25-30 European startups, with capital reserved for follow-ons into the strongest performers (evidenced by continued participation in Reformed's Series A and Pacifico BioLabs' Series A after initial seed checks).
Check Size
Public reporting on Fund III puts first checks in the $100K-$2M range. Portfolio company round sizes cluster between $5M-$7M at seed/Series A, consistent with FoodLabs co-investing alongside other funds rather than filling entire rounds solo.
Lead Tendency
FoodLabs both leads and co-leads. The firm co-led DITTO's $6M seed round for menstrual-health supplements alongside Eka Ventures in July 2026, and has taken clear Lead positions on other seed deals, while also participating as a follow-on/syndicate investor in later rounds (Reformed's $22M Series A, Pacifico BioLabs' Series A).
Recent Activity
FoodLabs closed a EUR 105 million third fund to invest across agriculture, food security, and health, explicitly targeting 25-30 European startups. As of mid-2026, the firm counts roughly 64 portfolio companies with 8 new investments in the trailing 12 months. The most recent confirmed round: co-lead of DITTO's $6M seed (July 2026). The firm also backed a follow-on into Reformed's $22M Series A (functional coffee/matcha, July 2026) and participated in Aardaia's seed round and Pacifico BioLabs' Series A.
Portfolio Highlights
FoodLabs' roughly 49-company visible portfolio spans precision fermentation (Formo, dairy proteins from microbes), alternative protein and synbio (Infinite Roots, Microharvest, Kynda Biotech, Dendro), regenerative agriculture and soil health (Klim), carbon removal (InPlanet), and consumer nutrition/health brands (DITTO, Ahead, Una Health, Myota). Notable exits in the visible portfolio include Freda, Rollo Robotics, and Sanity Group. Gorillas, the rapid-grocery-delivery company, also appears as an early portfolio bet reflecting the firm's supply-chain thesis.
Team
FoodLabs runs a large, structured team spanning Investment, Studio (venture-building), Growth, and Operations functions:
- Christophe Maire, Founding Partner
- Patrick Noller, General Partner & Managing Director
- Thilo Winter, Operating Partner
- Florian Breiner, Operating Partner, Growth
- Franz Crux, Chief of Staff
- Adrian Friederich, Principal, Investment
- Julius Strauss, Principal, Investment
- Nicolaus Norden, Associate, Investment
- Tiago Morelli, Associate, Investment
- Nora Spiekermann, Senior Analyst, Investment
- Valentin Bula, Head of Studio
- Ann-Cathrin Schulz, Associate, Studio
- Darius Zarrabian, Associate, Studio
- Till Hoelzer, Managing Director, Asia
- Lennart Schlegel, Manager, Investor Relations
- Michelle Fenner, Manager, PR, Brand & Communications
- Lutz Westerkamp, Growth Specialist
- Finn Styrnal, Growth Specialist
- Jana Granig, Senior Finance Manager
- Christophe Wagner, Interim CFO
- Paulina Gleitz, Office Manager
Decision Process
FoodLabs operates as a full investment partnership with a dedicated Investment team (Founding Partner, GP, Principals, Associates, Analyst) separate from its Studio (venture-building) arm and Growth/Operations staff. The scale and specialization of the team suggests deal decisions run through partner review rather than a single solo GP call, and the presence of a dedicated Studio team signals deep, hands-on involvement with portfolio companies beyond passive capital.
Founder Preferences
FoodLabs' messaging emphasizes backing "bold" and "audacious" founders willing to challenge conventional food production. The firm favors technical/scientific founding teams in synbio and fermentation, alongside consumer-brand operators in the nutrition and functional-food space, provided the underlying thesis ties back to planetary or human health impact.
Geographic Focus
Primarily Europe, headquartered in Berlin, Germany, with an explicit fund mandate to deploy across 25-30 European startups. The firm also maintains a Managing Director, Asia (Till Hoelzer), indicating selective activity or LP/portfolio ties in that region.